OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS

Clinical trials for OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS explained in plain language.

Never miss a new study

Get alerted when new OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS trials appear

Sign up with your email to follow new studies for OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet recruiting 2 Completed 1

CBD tested as shield against Chemo's numbing side effect

Symptom relief Recruiting now

This early-stage study is exploring whether taking CBD capsules can help prevent nerve damage (neuropathy) caused by a common chemotherapy drug called oxaliplatin. The trial will involve 30 people with colorectal cancer who are scheduled to receive oxaliplatin treatment. Particip…

Matched conditions: OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS

Phase: EARLY_PHASE1 • Sponsor: Fox Chase Cancer Center • Aim: Symptom relief

Last updated Mar 30, 2026 14:29 UTC

OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS

Get alerted when new OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS trials appear

CBD tested as shield against Chemo's numbing side effect